A detailed history of Advisors Asset Management, Inc. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 5,587 shares of CORT stock, worth $170,403. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,587
Previous 532 950.19%
Holding current value
$170,403
Previous $17,000 723.53%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$21.1 - $27.46 $106,660 - $138,810
5,055 Added 950.19%
5,587 $140,000
Q4 2023

Feb 14, 2024

BUY
$24.82 - $32.88 $13,204 - $17,492
532 New
532 $17,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $3.27B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Advisors Asset Management, Inc. Portfolio

Follow Advisors Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.